Back to ZACKS INVESTMENT MANAGEMENT ZACKS INVESTMENT MANAGEMENT

NKTRNKTR
2 quarters

Position history for ZACKS INVESTMENT MANAGEMENTZACKS INVESTMENT MANAGEMENT's holdings in Nektar Therapeutics

ZACKS INVESTMENT MANAGEMENT previously held 0 shares of NKTR (Nektar Therapeutics), worth $0 as of 2025-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$24,524

Total Shares Change

-36,065

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$25.76
0
2025-Q1
New
36,065
-
$24,5240.0%$11.10
26

Other major holders of NKTR: BNP PARIBAS FINANCIAL MARKETS, Invesco Ltd., PRIMECAP MANAGEMENT CO/CA/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used